Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.

[1]  Ding‐Shinn Chen,et al.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management , 2013, Hepatology International.

[2]  Ying Zhu,et al.  Inducible Interleukin 32 (IL-32) Exerts Extensive Antiviral Function via Selective Stimulation of Interferon λ1 (IFN-λ1)* , 2013, The Journal of Biological Chemistry.

[3]  Donghai Li,et al.  Major Vault Protein Regulates Class A Scavenger Receptor-mediated Tumor Necrosis Factor-α Synthesis and Apoptosis in Macrophages* , 2013, The Journal of Biological Chemistry.

[4]  Mengji Lu,et al.  Hepatitis B virus polymerase impairs interferon‐α–induced STA T activation through inhibition of importin‐α5 and protein kinase C‐δ , 2013, Hepatology.

[5]  Ding‐Shinn Chen,et al.  Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads , 2013, Hepatology.

[6]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[7]  Jianguo Wu,et al.  Major vault protein: A virus‐induced host factor against viral replication through the induction of type‐I interferon , 2012, Hepatology.

[8]  Jianguo Wu,et al.  Hepatitis B Virus-Induced Calreticulin Protein Is Involved in IFN Resistance , 2012, The Journal of Immunology.

[9]  Osamu Takeuchi,et al.  The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR–IL-1R by controlling degradation of regnase-1 , 2011, Nature Immunology.

[10]  S. Locarnini,et al.  The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. , 2011, Journal of hepatology.

[11]  R. Coffman,et al.  Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. , 2011, Immunity.

[12]  J. Qin,et al.  Hepatitis B Virus Regulatory HBx Protein Binds to Adaptor Protein IPS-1 and Inhibits the Activation of Beta Interferon , 2010, Journal of Virology.

[13]  M. Maini,et al.  Innate and Adaptive Immune Responses in Hepatitis B Virus Infection , 2010, Digestive Diseases.

[14]  Zhenghong Yuan,et al.  Inhibition of Hepatitis B Virus Replication by MyD88 Involves Accelerated Degradation of Pregenomic RNA and Nuclear Retention of Pre-S/S RNAs , 2010, Journal of Virology.

[15]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[16]  M. Mondelli,et al.  Is response to antiviral treatment influenced by hepatitis B virus genotype? , 2010, Journal of hepatology.

[17]  Zhan-qing Zhang,et al.  HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. , 2009, Molecular immunology.

[18]  Rachel Wilson,et al.  Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro , 2009, Antiviral therapy.

[19]  G. Gerken,et al.  Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells , 2009, Hepatology.

[20]  Osamu Takeuchi,et al.  Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2 , 2008, Nature Immunology.

[21]  S. Gygi,et al.  Host Resistance to Lung Infection Mediated by Major Vault Protein in Epithelial Cells , 2007, Science.

[22]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[23]  S. Schaefer,et al.  Hepatitis B virus taxonomy and hepatitis B virus genotypes. , 2007, World journal of gastroenterology.

[24]  Yuxiang Zhou,et al.  Genomic Analysis of Anti-Hepatitis B Virus (HBV) Activity by Small Interfering RNA and Lamivudine in Stable HBV-Producing Cells , 2005, Journal of Virology.

[25]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[26]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[27]  J. Rodés,et al.  Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. , 2002, Gastroenterology.

[28]  A. Lok,et al.  Clinical significance of hepatitis B virus genotypes , 2002, Hepatology.

[29]  Holger Wesche,et al.  IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[31]  D. Levy,et al.  The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. , 2001, Cytokine & growth factor reviews.

[32]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[33]  R. Repp,et al.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients , 1997, Journal of virology.

[34]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[35]  Y. Ohashi,et al.  Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part II: Evaluation of epidemiological factors and suspected risk factors of liver dysfunction. , 1991, The American journal of gastroenterology.

[36]  Y. Ohashi,et al.  Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers. , 1991, The American journal of gastroenterology.

[37]  U. Spengler,et al.  Immune response of peripheral blood mononuclear cells to HBx‐antigen of hepatitis B virus , 1991, Hepatology.

[38]  G. Colucci,et al.  Hepatitis B virus transcripts and surface antigen in human peripheral blood lymphocytes , 1990, Journal of medical virology.

[39]  W. Berger,et al.  Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity , 2008, Cellular and Molecular Life Sciences.

[40]  H. Bismuth,et al.  Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. , 1986, Journal of hepatology.